Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone: An Outpatient Detoxification for Opioid Dependence.

Trial Profile

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone: An Outpatient Detoxification for Opioid Dependence.

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 21 Apr 2017

At a glance

  • Drugs Naltrexone (Primary) ; Naltrexone (Primary) ; Buprenorphine/naloxone
  • Indications Opioid abuse
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Apr 2017 Planned primary completion date changed from 1 Sep 2015 to 1 Sep 2017.
    • 25 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top